CGTX - CIK 0001455365
COGNITION THERAPEUTICS INC (CGTX) reported net income of -$23.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$23.49M | +30.9% |
| FY 2024 | -$33.97M | -31.7% |
| FY 2023 | -$25.79M | -20.5% |
| FY 2022 | -$21.40M | -82.6% |
| FY 2021 | -$11.72M | -49.5% |
| FY 2020 | -$7.84M | - |
COGNITION THERAPEUTICS INC (CGTX) reported net income of -$23.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, COGNITION THERAPEUTICS INC's net income declined from -$7.84M to -$23.49M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.